Fibromyalgia syndrome is a chronic and debilitating disorder characterized
by widespread nonarticular musculoskeletal pain whose etiology is unknown.
Many of the symptoms of this syndrome, including difficulty sleeping, fatig
ue, malaise, myalgias, gastrointestinal complaints, and decreased cognitive
function, are similar to those observed in individuals whose circadian pac
emaker is abnormally aligned with their sleep-wake schedule or with local e
nvironmental time. Abnormalities in melatonin and cortisol, two hormones wh
ose secretion is strongly influenced by the circadian pacemaker, have been
reported in women with fibromyalgia. We studied the circadian rhythms of 10
women with fibromyalgia and 12 control healthy women. The protocol control
led factors known to affect markers of the circadian system, including ligh
t levels, posture, sleep-wake state, meals, and activity. The timing of the
events in the protocol were calculated relative to the habitual sleep-wake
schedule of each individual subject. Under these conditions, we found no s
ignificant difference between the women with fibromyalgia and control women
in the circadian amplitude or phase of rhythms of melatonin, cortisol, and
core body temperature. The average circadian phases expressed in hours pos
thabitual bedtime for women with and without fibromyalgia were 3:43+/-0:19
and 3:46+/-0:13, respectively, for melatonin; 10:13+/-0:23 and 10:32+/-0:20
, respectively for cortisol; and 5:19+/-0:19 and 4:57+/-0:33, respectively,
for core body temperature phases. Both groups of women had similar circadi
an rhythms in self-reported alertness. Although pain and stiffness were sig
nificantly increased in women with fibromyalgia compared with healthy women
, there were no circadian rhythms in either parameter. We suggest that abno
rmalities in circadian rhythmicity are not a primary cause of fibromyalgia
or its symptoms.